Cvs Health Corporation (NYSE:CVS)

CAPS Rating: 4 out of 5

The Company's current operations are grouped into two businesses: Retail Pharmacy and Pharmacy Benefit Management.

Results 1 - 20 of 296 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar fool1965 (< 20) Submitted: 1/23/2015 6:50:05 AM : Outperform Start Price: $100.19 CVS Score: +2.01

I dunno

Recs

0
Member Avatar madhazel (< 20) Submitted: 1/18/2015 7:01:42 PM : Outperform Start Price: $99.09 CVS Score: +1.58

Aging population needing meds, convenience, newer modern stores

Recs

0
Member Avatar JoeBEan769 (82.57) Submitted: 1/4/2015 11:44:42 AM : Outperform Start Price: $94.26 CVS Score: +7.66

There is no doubt in my mind that CVS will compliment WAG going forward.

Recs

0
Member Avatar MightyMinnow (21.89) Submitted: 12/23/2014 8:55:54 AM : Underperform Start Price: $97.31 CVS Score: -6.22

Nonprescription nosebleed remedy works 1st dose.

Recs

0
Member Avatar Staka (96.92) Submitted: 12/20/2014 12:05:21 PM : Outperform Start Price: $95.47 CVS Score: +7.54

Positive:
- Profits from wasted Obamacare money
- Defensive sector, steady cash generator
- Long term growth due to aging population

Negative:
- Chart quite extended, could correct in the short term

Category: BVm

Recs

0
Member Avatar paul0574 (< 20) Submitted: 11/12/2014 3:22:13 PM : Outperform Start Price: $89.10 CVS Score: +13.77

because i need it to

Recs

0
Member Avatar RiverRover (90.75) Submitted: 11/3/2014 10:19:36 PM : Outperform Start Price: $84.55 CVS Score: +18.49

Great business with widespread influence. Stopped selling tobacco products which are bad for health. Involved in pharmacy benefits management. Second largest pharmacy business in the USA.

Recs

0
Member Avatar S2kT (65.96) Submitted: 10/1/2014 7:57:53 PM : Outperform Start Price: $78.44 CVS Score: +18.83

well positioned for long term growth in the healthcare industry.

Recs

0
Member Avatar hba24 (95.76) Submitted: 5/28/2014 10:19:05 AM : Outperform Start Price: $76.57 CVS Score: +25.68

The decision to stop selling tobacco and cigarettes will likely have a short-term negative affect on sales and earnings, but in the long run it's a socially responsible decision that I think customers will reward with increased brand loyalty as the company shifts its focus more toward the "care" part of it's name. I like this move by CVS.

Recs

0
Member Avatar Med51 (63.46) Submitted: 5/8/2014 1:15:26 PM : Outperform Start Price: $75.19 CVS Score: +26.41

With a great business model and more costumers being able to access the pharmacy through insurance there should be a growth in not only Top line but store front items.

Recs

0
Member Avatar maklevisha (< 20) Submitted: 4/28/2014 7:12:27 PM : Outperform Start Price: $72.90 CVS Score: +30.15

Decreasing margin gap between wal-mart on consumer good products. Introduction of erwards program and quick accessibility of prescriptions. Look for a CVS coming to a corner near you.

Recs

0
Member Avatar racoveanul (80.38) Submitted: 4/12/2014 3:05:27 PM : Outperform Start Price: $72.14 CVS Score: +28.93

CVS has an A for financial health and a PEG less than 1 on Morningstar, so it's one of my long picks.

Recs

0
Member Avatar Dividends500 (86.29) Submitted: 3/26/2014 4:40:46 PM : Outperform Start Price: $67.24 CVS Score: +37.84

Dividends500 tracks the 200 strongest dividends in the S&P 500. To qualify as a strong dividend, the company must meet two simple requirements:

- A payout ratio below 50%
- An increasing dividend from the prior year

Because there are more than 200 dividend paying companies in the S&P 500 that meet these requirements, the qualifying companies with the largest dividend yields were chosen.

Dividends500 intends to test this FactSet article, which highlights these strong dividend paying companies and their outperformance versus the S&P 500 as a whole (Page 12).

http://www.factset.com/websitefiles/PDFs/dividend/dividend_12.16.13

If you have questions or see something you think is inaccurate feel free to let me know.

Recs

0
Member Avatar AlexeiVronsky (97.58) Submitted: 3/13/2014 4:38:39 AM : Outperform Start Price: $70.41 CVS Score: +33.40

SA Pick, took a small stake

Recs

0
Member Avatar bryanb426 (< 20) Submitted: 3/7/2014 3:16:52 PM : Outperform Start Price: $72.41 CVS Score: +31.39

dominating the market for consumer drugs, smart play to eliminate tobacco sales (others will follow), expansion to other high margin products (aka walmart and target)

Recs

0
Member Avatar BaseBawl (34.69) Submitted: 3/7/2014 9:29:51 AM : Outperform Start Price: $72.45 CVS Score: +31.81

Ian Wyatt.

Recs

0
Member Avatar Thos (< 20) Submitted: 3/6/2014 2:06:10 PM : Outperform Start Price: $72.34 CVS Score: +31.62

David's new stock, CVS, perplexes me as a retired Longs/CVS employee. I have read the CVS article in the Stock Advisor, but cannot understand how CVS can be as successful as it appears to be when all of the employees I know just hate working there, especially those who previously worked for Longs, many whom have since quit.

Recs

1
Member Avatar Gtrinvestor (99.73) Submitted: 2/21/2014 11:52:31 AM : Outperform Start Price: $70.24 CVS Score: +33.78

Company just announced discontinuing the sale of cigarettes. Okay, so why be optimistic about a company that is cutting out a lot of revenue... because it shows me that they are truly thinking strategically for the long-term (not just quarter to quarter). They are trying to convert themselves into a medical provider, not just a place to buy asprin, milk and a birthday card. I can see them further expanding their Minute Clinic concept into other areas, which should help profitability quite a bit.

Recs

0
Member Avatar herodotous (< 20) Submitted: 2/4/2014 1:52:25 AM : Outperform Start Price: $65.51 CVS Score: +38.01

Excellent customer service and thoughtful expansion plans with diligent management.

Recs

0
Member Avatar stocky5 (40.76) Submitted: 1/22/2014 10:08:16 AM : Outperform Start Price: $67.96 CVS Score: +38.35

CVS is selling at over a 40% discount to the S&P 500, with a Forward PEG of 1.1. Analysts are raising price targets, and earnings have been met or exceeded in each of the last 6 reporting quarters. The recent weakness in price has created a good entry point, as the stock is currently oversold.

Featured Broker Partners


Advertisement